Core Viewpoint - Mengjie Co., Ltd. reported a revenue of 1.099 billion yuan for the first three quarters of 2025, a year-on-year decrease of 7.97%, while the net profit attributable to shareholders increased by 28.69% to 26.5176 million yuan [1]. Group 1: Financial Performance - The company's revenue for the first three quarters of 2025 was 1.099 billion yuan, reflecting a decline of 7.97% compared to the previous year [1]. - The net profit attributable to shareholders reached 26.5176 million yuan, marking an increase of 28.69% year-on-year [1]. Group 2: Board Disagreement - Director Chen Jie voted against the third-quarter report, expressing concerns over the accuracy and completeness of the financial data, citing potential false records and misleading statements [1][4]. - Chen Jie highlighted issues regarding the financial management and internal controls of the company, particularly related to loans made to Ye Yifeng, which amounted to 63.3763 million yuan as of September 30, 2025 [4]. Group 3: Regulatory Issues - The company received an administrative regulatory decision from the Hunan Securities Regulatory Bureau, indicating that its subsidiary, Fujian Dafang Sleep Technology Co., Ltd., provided financial assistance to Ye Yifeng through inter-company transactions [4][5]. - The regulatory decision also pointed out issues with revenue and cost recognition, as well as employee compensation and social security, which were not addressed in the third-quarter report, leading to concerns about the credibility of the financial data [5]. Group 4: Company Response - Mengjie Co., Ltd. acknowledged the issues raised in the regulatory decision and stated that it would take corrective actions as required [7]. - The company has initiated recovery efforts for the funds owed by Ye Yifeng and has signed agreements to secure repayment, including pledging shares as collateral [7].
这份三季报,董事有异议!